Debreceno vaistinė

UAB „Debreceno vaistinė“ was established on the 5th of November, 1993. Company’s main activity is medicines production and sale.
Financial results
P/L Statment
2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|
Revenue | 503 | 533 | 573 | 691 |
Cost of goods sold | 262 | 307 | 339 | 407 |
Gross profit (loss) | 241 | 226 | 234 | 284 |
Gross profit margin | 48% | 42% | 41% | 41% |
Operating expenses | 75 | 74 | 80 | 109 |
Operating profit (loss) | -1 | -7 | -8 | -9 |
Operating profit margin | -0% | -1% | -1% | -1% |
EBITDA | 7 | 2 | 3 | 14 |
EBITDA margin | 1% | 0% | 0% | 2% |
Net profit (loss) | 5 | 1 | 1 | 2 |
Net profit margin | 1% | 0% | 0% | 0% |
Balance sheet
2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|
Non-current assets | 55 | 54 | 511 | 502 |
Intangible assets | ||||
Tangible assets | 55 | 54 | 511 | 502 |
Financial assets | ||||
Other non-current assets | ||||
Current assets | 68 | 71 | 71 | 81 |
Inventories and prepaid expenses | 54 | 56 | 47 | 47 |
Accounts receivable in one year | 12 | 13 | 21 | 22 |
Other current assets | ||||
Cash and cash equivalents | 2 | 2 | 3 | 12 |
Total assets | 123 | 125 | 583 | 583 |
Equity | 90 | 87 | 546 | 548 |
Grants and subsidies | ||||
Liabilities | 33 | 38 | 36 | 36 |
Financial liabilities | 0 | 0 | 0 | 0 |
Long-term liabilities | ||||
Short-term liabilities | 33 | 38 | 36 | 36 |
Equity and liabilities | 123 | 125 | 583 | 584 |
Financial ratios
2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|
Capital return ratios | ||||
Return on assets (ROA) | 5% | 1% | 0% | 0% |
Return on equity (ROE) | 6% | 1% | 0% | 0% |
Return on capital employed (ROCE) | -1% | -8% | -1% | -2% |
Capital structure and liquidity ratios | ||||
Debt / asset ratio (D/A) | 0.00 | 0.00 | 0.00 | 0.00 |
Current Ratio | 2.05 | 1.89 | 1.96 | 2.29 |
Quick ratio | 0.42 | 0.40 | 0.65 | 0.97 |
Turnover ratios | ||||
Asset turnover | 4.09 | 4.28 | 0.98 | 1.18 |
Fixed asset turnover | 9.11 | 9.91 | 1.12 | 1.38 |
Equity turnover | 5.59 | 6.12 | 1.05 | 1.26 |
Profitability ratios | ||||
EBITDA margin | 1% | 0% | 0% | 2% |
Operating profit margin | -0% | -1% | -1% | -1% |
Net profit margin | 1% | 0% | 0% | 0% |
Other ratios | ||||
Dividends to the Municipality | 4.00 | 0.90 | 1.00 | 2.10 |
Dividends paid / net profit | 0.74 | 0.82 | 0.77 | 0.86 |
Financial statments
Expectations of the municipal
About the company
- Official nameUAB „Debreceno vaistinė“
- Legal formPrivate limited liability company (UAB)
- Company code140786882
- SectorOther
- Line of businessPharmacy activities
- Representing institutionKlaipėda city municipality
- Share belonging to the Municipal100%
Return to the Municipality
2 EUR thousand
ROE
0.4%
Number of employees
14
Financial data provided as at end-December 2022
Management
- Justinas ŠčėsnaChief Executive Officer
Information as of: 2023/04/30